David Perez
David Perez
Chairman, Blood Management Business, Terumo Corporation
President and CEO, Caridian BCT and Terumo Transfusion
CaridianBCT and Terumo Transfusion
David Perez is president and chief executive officer of CaridianBCT, the leading global provider of innovative technologies and services specializing in automated blood collections, therapeutic apheresis and cell therapy systems, whole blood processes and pathogen reduction technologies. Under Perez’s leadership direction, the company serves patients through its commitment and vision, “For Better Blood and Better Lives” by developing and commercializing products to support customers in the blood banking, transfusion medicine and cellular therapy industries. He has close to 30 years of experience in medical device and health care service businesses, serving in a variety of leadership positions. In his role at CaridianBCT, Perez leads the strategic direction, growth and execution of a global company selling products in more than 90 countries. He also drives the company’s mission to improve lives through innovation, quality and services delivered by CaridianBCT’s people, products and processes in blood component technologies.
Additionally, Perez serves the Advanced Medical Technology Association (AdvaMed) as a member of the board of directors and its Strategic Planning Committee, vice chair of the Technology and Regulatory Affairs Committee, and as the chair of the Blood Products and Technology Sector. Perez also serves as the vice chair of the board of trustees for the National Blood Foundation (NBF), as a member on the NBF Council on Research and Development, and a board member of both the Foundation for America’s Blood Centers® and the Colorado BioScience Association.
Prior to joining CaridianBCT in 1999, Perez held leadership positions at UroTherapies Inc., Haemonetics® Corp., Caremark LLC, Coram Healthcare Corp. and Kendall. He earned his bachelor’s degree in political science from Texas Tech University.
